Onglyza (saxagliptin)

pCPA File Number: 20733
Negotiation Status:
Concluded with an LOI
Indication(s):
Diabetes Mellitus, Type 2
Sponsor/Manufacturer:
AstraZeneca Canada Inc.
CDA-AMC Project Number:
SR0329-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: